Enasidenib Approved for AML, but Best Uses Unclear

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Enasidenib Approved for AML, but Best Uses Unclear
Authors
Keywords
-
Journal
Cancer Discovery
Volume 7, Issue 10, Pages OF4-OF4
Publisher
American Association for Cancer Research (AACR)
Online
2017-08-18
DOI
10.1158/2159-8290.cd-nb2017-117

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.